comparemela.com

Latest Breaking News On - Sigma securities - Page 1 : comparemela.com

Wag! Group Co. (NASDAQ:PET) COO Dylan Allread Sells 9,981 Shares

Wag! Group Co. (NASDAQ:PET) COO Dylan Allread Sells 9,981 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dylan-allread
Group-stock-performance
Sigma-securities
Group-co
Nasdaq
Vanguard-group-inc
Group-daily
Geode-capital-management
Get-free-report
Group-stock
Capital-management
Two-sigma-securities

ProQR Therapeutics (NASDAQ:PRQR) Price Target Increased to $2.00 by Analysts at Citigroup

ProQR Therapeutics (NASDAQ:PRQR) Price Target Increased to $2.00 by Analysts at Citigroup
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sigma-securities
Virtu-financial
Citigroup
Tower-research-capital
Proqr-therapeutics-company-profile
Belvedere-trading
Free-report
Moderate-buy
Get-free-report
Research-capital
Financial-markets

StockNews.com Begins Coverage on Fuel Tech (NASDAQ:FTEK)

StockNews.com assumed coverage on shares of Fuel Tech (NASDAQ:FTEK – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a hold rating on the industrial products company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $4.00 price objective on shares of Fuel Tech in a research […]

Tech-inc
Migdal-insurance-financial-holdings-ltd
Sigma-securities
Charles-schwab-investment-management-inc
Virtu-financial
Pollution-control-technology
Fuel-tech
Free-report
Get-free-report
Financial-holdings
Street-group

Wag! Group Co. (NASDAQ:PET) COO Dylan Allread Sells 35,855 Shares

Wag! Group Co. (NASDAQ:PET – Get Free Report) COO Dylan Allread sold 35,855 shares of the company’s stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $2.12, for a total transaction of $76,012.60. Following the sale, the chief operating officer now directly owns 439,555 shares of the […]

Dylan-allread
Group-co
Cerity-partners
Securities-exchange-commission
Sigma-securities
Nasdaq
Group-daily
Asset-management-inc
Group-company-profile
Group-trading
Get-free-report
Exchange-commission

Citigroup Raises ProQR Therapeutics (NASDAQ:PRQR) Price Target to $2.00

ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) had its target price lifted by analysts at Citigroup from $1.80 to $2.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s price objective suggests a potential upside of 2.56% from the company’s […]

Tower-research-capital
Belvedere-trading
Sigma-securities
Proqr-therapeutics-company-profile
Virtu-financial
Citigroup
Get-free-report
Research-capital
Financial-markets

vimarsana © 2020. All Rights Reserved.